Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Repeated dose toxicity: inhalation

Currently viewing:

Administrative data

short-term repeated dose toxicity: inhalation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
28 days
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
comparable to guideline study with acceptable restrictions
Purity of test substance not reported, whole body exposure in a test chamber.

Data source

Reference Type:
study report
Report date:

Materials and methods

Test guideline
equivalent or similar to guideline
OECD Guideline 412 (Subacute Inhalation Toxicity: 28-Day Study)
particle size distribution not determined
GLP compliance:
Limit test:

Test material

Constituent 1
Chemical structure
Reference substance name:
EC Number:
EC Name:
Cas Number:
Molecular formula:
Test material form:
solid: particulate/powder
Details on test material:
Dechlorane Plus 25, no further details reported
Particle Size Distribution
TI, for weeks 1 through 4
Total number counted: 330, 433, 507, 386 µm
smallest particles observed: 2.5, 2.5, 2.0, 2.5 µm
largest particles observed: 110, 131, 112, 106 µm
TII, for weeks 1 through 4
Total number counted: 362, 411, 433, 421 µm
smallest particles observed: 2.0, 2.5, 2.5, 2.5 µm
largest particles observed: 130, 154, 142, 159 µm

Test animals

other: Charles River COBS
Details on test animals or test system and environmental conditions:
Young adult rats, no further details reported.

Administration / exposure

Route of administration:
inhalation: dust
Type of inhalation exposure:
whole body
Remarks on MMAD:
MMAD / GSD: About 60% of particles with particle size of 10 µm or less.
Details on inhalation exposure:
Target concentrations of 0, 0.5, and 1.0 mg/l were administered for 6 hours per day for 5 days per week for 4 weeks.
Analytical verification of doses or concentrations:
Details on analytical verification of doses or concentrations:
Analytical concentrations of 0, 0.640, and 1.524 mg/l were determined, total dust weight per volume of air was recorded.
Duration of treatment / exposure:
6 hours per day for 5 days per week for 4 weeks.
Frequency of treatment:
5 days per week
Doses / concentrationsopen allclose all
Dose / conc.:
0 mg/L air (analytical)
Dose / conc.:
0.64 mg/L air (analytical)
Dose / conc.:
1.524 mg/L air (analytical)
No. of animals per sex per dose:
5 males and 5 females per dose
Control animals:
yes, concurrent vehicle
Details on study design:
Dechlorane Plus 25 was administered by inhalation for 6 hours per day for 5 days per week for 4 weeks to groups of 5 males and 5 females at concentrations of 0, 0.5, or 1.0 mg/l nominal concentration corresponding to 0, 0.64, and 1.524 mg/l analytical concentration.
Positive control:


Observations and examinations performed and frequency:
The following parameters were recorded: mortality daily, clinical signs of toxicity daily, bodyweights weekly, haematology at study start and end, clinical chemistry at study start and end, urinalyses at study start and end, macroscopic and microscopic pathology, organ weights.
Sacrifice and pathology:
All animals were subjected to macroscopic and microscopic pathology and organ weight determination.
Other examinations:
Haematolog and clinical chemistry including urinalysis.
not reported

Results and discussion

Results of examinations

Clinical signs:
no effects observed
no mortality observed
Body weight and weight changes:
no effects observed
Food consumption and compound intake (if feeding study):
not examined
Food efficiency:
not examined
Water consumption and compound intake (if drinking water study):
not examined
Ophthalmological findings:
not examined
Haematological findings:
no effects observed
Clinical biochemistry findings:
no effects observed
Urinalysis findings:
effects observed, treatment-related
Description (incidence and severity):
Slight diuresis in both treated groups
Behaviour (functional findings):
not examined
Organ weight findings including organ / body weight ratios:
effects observed, treatment-related
Description (incidence and severity):
increased liver and lung weights in both treated groups
Gross pathological findings:
no effects observed
Histopathological findings: non-neoplastic:
effects observed, treatment-related
Description (incidence and severity):
hepatocellular hypertrophy
Histopathological findings: neoplastic:
no effects observed
Details on results:
Increased liver weights with hepatocellular hypertrophy, increased lung weights without histological correlate, slight diuresis, all changes in both dose groups without dose-dependence, no clear adverse effect observed.

Effect levels

Key result
Dose descriptor:
Effect level:
1.524 mg/L air
Based on:
act. ingr.
Basis for effect level:
body weight and weight gain
clinical biochemistry
clinical signs
histopathology: neoplastic
histopathology: non-neoplastic
organ weights and organ / body weight ratios

Target system / organ toxicity

Critical effects observed:
not specified

Applicant's summary and conclusion

NOAEC at 1.524 mg/l dust in air with slight effects on liver and lung and slight functional effects on the kidneys, no clear adverse effect observed, all changes are compatible with functional adaption, but occurred in both dose groups.
Executive summary:

Groups of 5 male and 5 female rats were exposed to Dechlorane Plus for 6 hours per day for 5 days per week in whole body exposure chambers at nominal concentrations of nominal 0.5 and 1.0 mg/l corresponding to analytical 0.64 and 1.524 mg/l for 28 days. In both dose groups slightly increased liver weights with hepatocellular hypertrophy, slightly increased lung weights, and slight diuresis were seen without dose-dependence. No clear adverse effect occurred. The NOAEC was determined at 1.524 mg/l.